Shareholders' equity · 2014–2025
Rhythm Pharmaceuticals shareholders' equity
$139M+540.0% · FY2025
Rhythm Pharmaceuticals (RYTM) reported $139M in shareholders' equity for fiscal 2025, +540.0% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $139M | +540.0% | Open → |
| FY20242024-12-31 | $21.7M | −87.2% | Open → |
| FY20232023-12-31 | $170M | −35.8% | Open → |
| FY20222022-12-31 | $264M | −7.0% | Open → |
| FY20212021-12-31 | $284M | +70.6% | Open → |
| FY20202020-12-31 | $167M | −40.7% | Open → |
| FY20192019-12-31 | $281M | +14.1% | Open → |
| FY20182018-12-31 | $246M | +70.1% | Open → |
| FY20172017-12-31 | $145M | +$177M | Open → |
| FY20162016-12-31 | −$32.7M | −$24.7M | Open → |
| FY20152015-12-31 | −$8.0M | −$7.6M | Open → |
| FY20142014-12-31 | −$358,000 | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Rhythm Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/rhythm-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Rhythm Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/rhythm-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-rhythm-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Rhythm Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/rhythm-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-052533 · August 4, 2026
{{cite web |title=Rhythm Pharmaceuticals shareholders' equity — 10-Q (0001628280-26-052533) |url=https://www.sec.gov/Archives/edgar/data/1649904/000162828026052533/rytm-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.